1. Home
  2. EXAS vs FND Comparison

EXAS vs FND Comparison

Compare EXAS & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • FND
  • Stock Information
  • Founded
  • EXAS 1995
  • FND 2000
  • Country
  • EXAS United States
  • FND United States
  • Employees
  • EXAS N/A
  • FND N/A
  • Industry
  • EXAS Medical Specialities
  • FND RETAIL: Building Materials
  • Sector
  • EXAS Health Care
  • FND Consumer Discretionary
  • Exchange
  • EXAS Nasdaq
  • FND Nasdaq
  • Market Cap
  • EXAS 10.6B
  • FND 9.0B
  • IPO Year
  • EXAS N/A
  • FND 2017
  • Fundamental
  • Price
  • EXAS $57.01
  • FND $72.16
  • Analyst Decision
  • EXAS Strong Buy
  • FND Hold
  • Analyst Count
  • EXAS 21
  • FND 15
  • Target Price
  • EXAS $67.86
  • FND $89.13
  • AVG Volume (30 Days)
  • EXAS 2.3M
  • FND 2.1M
  • Earning Date
  • EXAS 11-04-2025
  • FND 10-29-2025
  • Dividend Yield
  • EXAS N/A
  • FND N/A
  • EPS Growth
  • EXAS N/A
  • FND N/A
  • EPS
  • EXAS N/A
  • FND 1.94
  • Revenue
  • EXAS $2,939,949,000.00
  • FND $4,600,232,000.00
  • Revenue This Year
  • EXAS $16.68
  • FND $6.49
  • Revenue Next Year
  • EXAS $12.08
  • FND $8.64
  • P/E Ratio
  • EXAS N/A
  • FND $37.97
  • Revenue Growth
  • EXAS 12.55
  • FND 4.88
  • 52 Week Low
  • EXAS $38.81
  • FND $66.01
  • 52 Week High
  • EXAS $72.83
  • FND $122.90
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 68.53
  • FND 31.70
  • Support Level
  • EXAS $52.85
  • FND $72.00
  • Resistance Level
  • EXAS $54.74
  • FND $75.75
  • Average True Range (ATR)
  • EXAS 1.40
  • FND 2.77
  • MACD
  • EXAS 0.17
  • FND -1.21
  • Stochastic Oscillator
  • EXAS 93.39
  • FND 5.47

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: